Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts.
Beauverd Y, Morin S, Nabergoj M, Stephan C, De Ramon Ortiz C, Mamez AC, Mahne E, Petropoulou A, Giannotti F, Ayer C, Bruno B, Bounaix L, Anastasiou M, Mappoura M, Tran TA, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: de ramon ortiz c. Transplant Cell Ther. 2021 Jan;27(1):67.e1-67.e7. doi: 10.1016/j.bbmt.2020.09.022. Epub 2020 Sep 24. Transplant Cell Ther. 2021. PMID: 32980547 Free article.
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Beauverd Y, Morin S, Stephan C, De Ramon Ortiz C, Fabra Urdiola M, Giannotti F, Mahne E, Mamez AC, Mappoura M, Simonetta F, Tran TA, Ayer C, Noetzlin S, Verdon I, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: de ramon ortiz c. Bone Marrow Transplant. 2021 Sep;56(9):2284-2286. doi: 10.1038/s41409-021-01334-6. Epub 2021 May 18. Bone Marrow Transplant. 2021. PMID: 34007052 No abstract available.
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Chalandon Y, Mamez AC, Giannotti F, Beauverd Y, Dantin C, Mahne E, Mappoura M, Bernard F, de Ramon Ortiz C, Stephan C, Morin S, Ansari M, Simonetta F, Masouridi-Levrat S. Chalandon Y, et al. Among authors: de ramon ortiz c. Transplant Cell Ther. 2022 Nov;28(11):765.e1-765.e9. doi: 10.1016/j.jtct.2022.08.003. Epub 2022 Aug 8. Transplant Cell Ther. 2022. PMID: 35953029 Free article.
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
De Ramón Ortiz C, Justo Sanz R, Beauverd Y, Humala K, López de la Guia A, De Paz R, Gasior M, Gómez Prieto P, Fabra Urdiola M, Canales Albendea M, Butta N, Jiménez Yuste V. De Ramón Ortiz C, et al. Dis Markers. 2023 Apr 17;2023:7589017. doi: 10.1155/2023/7589017. eCollection 2023. Dis Markers. 2023. PMID: 37101837 Free PMC article.
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report.
Giannotti F, De Ramon Ortiz C, Simonetta F, Morin S, Bernardi C, Masouridi-Levrat S, Chalandon Y, Mamez AC. Giannotti F, et al. Among authors: de ramon ortiz c. Front Immunol. 2024 Mar 6;15:1360275. doi: 10.3389/fimmu.2024.1360275. eCollection 2024. Front Immunol. 2024. PMID: 38510239 Free PMC article.
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P; PERSEUS Trial Investigators. Sonneveld P, et al. N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12. N Engl J Med. 2024. PMID: 38084760 Clinical Trial.